A 380-gene meta-signature of active tuberculosis compared with healthy controls

European Respiratory Journal

Volumn 47, Issue 6, 2016, Pages 1873-1876

  Blankley, Simon ^a   Graham, Christine M ^a   Levin, Joe ^a   Turner, Jacob ^b   Berry, Matthew P R ^a,c   Bloom, Chloe I ^a   Xu, Zhaohui ^d   Pascual, Virgina ^d   Banchereau, Jacques ^e   Chaussabel, Damien ^f   Breen, Ronan ^g   Santis, George ^g   Blankenship, Derek M ^b   Lipman, Marc ^h,i   O'Garra, Anne ^a,j  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^b SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

^c ST MARY S HOSPITAL   (United Kingdom)

^d BAYLOR INSTITUTE FOR IMMUNOLOGY RESEARCH   (United States)

^e JACKSON LABORATORY   (United States)

^f SIDRA MEDICAL AND RESEARCH CENTER   (Qatar)

^g KING'S COLLEGE LONDON   (United Kingdom)

^h ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

ⁱ UNIVERSITY COLLEGE LONDON   (United Kingdom)

^j IMPERIAL COLLEGE LONDON   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GAMMA INTERFERON; MESSENGER RNA; TRANSCRIPTOME;

ADAPTIVE IMMUNITY; CONTROLLED STUDY; DATA ANALYSIS; GENE CONTROL; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC TRANSCRIPTION; HUMAN; INNATE IMMUNITY; LETTER; MEDLINE; METHODOLOGY; PRIORITY JOURNAL; TUBERCULOSIS; GENE EXPRESSION PROFILING; GENETICS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; META ANALYSIS; SIGNAL TRANSDUCTION;

GENE EXPRESSION PROFILING; HOST-PATHOGEN INTERACTIONS; HUMANS; SIGNAL TRANSDUCTION; TRANSCRIPTOME; TUBERCULOSIS;

EID: 84973504332     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/13993003.02121-2015     Document Type: Letter

References (15)

1. World Health Organization. Global tuberculosis report 2014. Geneva, World Health Organization, 2014. Available from: http://apps.who.int/iris/bitstream/10665/137094/1/9789241564809-eng.pdf
2. Blankley S, Berry MP, Graham CM, et al. The application of transcriptional blood signatures to enhance our understanding of the host response to infection: the example of tuberculosis. Philos Trans R Soc Lond B Biol Sci 2014; 369: 20130427.
3. Kaforou M, Wright VJ, Oni T, et al. Detection of tuberculosis in HIV-infected and -uninfected African adults using whole blood RNA expression signatures: a case-control study. PLoS Med 2013; 10: e1001538.
4. Berry MP, Graham CM, McNab FW, et al. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 2010; 466: 973-977.
5. Joosten SA, Fletcher HA, Ottenhoff TH. A helicopter perspective on TB biomarkers: pathway and process based analysis of gene expression data provides new insight into TB pathogenesis. PLoS One 2013; 8: e73230.
6. Bloom CI, Graham CM, Berry MP, et al. Detectable changes in the blood transcriptome are present after two weeks of antituberculosis therapy. PLoS One 2012; 7: e46191.
7. Cliff JM, Lee JS, Constantinou N, et al. Distinct phases of blood gene expression pattern through tuberculosis treatment reflect modulation of the humoral immune response. J Infect Dis 2013; 207: 18-29.
8. Smid M, Dorssers LC, Jenster G. Venn Mapping: clustering of heterologous microarray data based on the number of co-occurring differentially expressed genes. Bioinformatics 2003; 19: 2065-2071.
9. Rhodes DR, Yu J, Shanker K, et al. Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. Proc Natl Acad Sci USA 2004; 101: 9309-9314.
10. Chaussabel D, Quinn C, Shen J, et al. A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus. Immunity 2008; 29: 150-164.
11. Saiga H, Kitada S, Shimada Y, et al. Critical role of AIM2 in Mycobacterium tuberculosis infection. Int Immunol 2012; 24: 637-644.
12. Tussiwand R, Lee WL, Murphy TL, et al. Compensatory dendritic cell development mediated by BATF-IRF interactions. Nature 2012; 490: 502-507.
13. Jacobsen M, Repsilber D, Gutschmidt A, et al. Candidate biomarkers for discrimination between infection and disease caused by Mycobacterium tuberculosis. J Mol Med 2007; 85: 613-621.
14. Kasvosve I, Gomo ZA, Mvundura E, et al. Haptoglobin polymorphism and mortality in patients with tuberculosis. Int J Tuberc Lung Dis 2000; 4: 771-775.
15. O'Garra A, Redford PS, McNab FW, et al. The immune response in tuberculosis. Annu Rev Immunol 2013; 31: 475-527.